In humans, AD-associated soluble persistently phosphorylated tau as indexed by the AT8 antibody first appears in the LC in a minority of individuals prepubertally [2] but is observed nearly universally by 40 years of age [1, 3]. Here, MAPT is linked to Alzheimer disease.